Check out part 2 in our 3-part series on how to optimize PMA outcomes for combinations while working within the current environmental constraints!
To work within the “status quo” environment that oncology combination therapies face in regards to market access, Walter Colasante, Ashley Fraser, and Owen Male of Charles River Associates examine the right questions and decisions companies must ask during clinical development:
⏰ One day left to register! 📆 Join Citeline's expert analysts June 12, as they dissect the major announcements, clinical trial results, and emerging therapies revealed at this year’s ASCO Annual Meeting. Here’s what you can expect: • Comprehensive highlights • Strategic analysis • Market implications • Licensing opportunities And a live Q&A, so you can hear from the experts as they answer your pressing questions on the future of oncology care. Register for the webinar today: https://ow.ly/pJXF50S8AcW. #ASCOAnnualMeeting #MarketIntelligence #ClinicalTrials #OncologyTrends #WebinarAlert #OncologyInsights
⏰ One day left to register! 📆 Join Citeline's expert analysts June 12, as they dissect the major announcements, clinical trial results, and emerging therapies revealed at this year’s ASCO Annual Meeting. Here’s what you can expect: • Comprehensive highlights • Strategic analysis • Market implications • Licensing opportunities And a live Q&A, so you can hear from the experts as they answer your pressing questions on the future of oncology care. Register for the webinar today: https://ow.ly/T4SR50S8Ahr. #ASCOAnnualMeeting #MarketIntelligence #ClinicalTrials #OncologyTrends #WebinarAlert #OncologyInsights
Inside Sales Manager-CRO-Changing the present;"Every great advance in science has issued from a new audacity of the imagination." John Dewey #fortreaforward #experiencematters
Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Fortrea's blog explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/gSyfYzEP #clinicaltrials #research #drugdevelopment
Passionate Life Sciences Leader | Fast-Tracking Treatments for Patients | Making a Positive Difference ❤️ | HBA Ambassador Champion | WEN (Women Empowerment Network) India Co-Lead
Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Fortrea's blog explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/gKGYTwJP #clinicaltrials #research #drugdevelopment
To mark #WorldCancerDay, our team of #realworld experts highlight 10 key facts in our new infographic, spanning real world evidence generation in oncology and its benefits to patients. Fact 1 highlights RWE's crucial role in #precisionmedicine. Download the Infographic to find out more! https://bit.ly/42pSUd1
Unlocking the full picture in cancer treatment goes beyond survival – it's about enhancing Quality of Life (QoL). Read Kelly Dumais's article on how prioritizing patient-reported outcomes (PROs) can enhance study designs and elevate your drug's market position: • PROs in study design: Uncover how patient insights enhance oncology trials. • Therapy differentiation: Learn the role of PROs in setting your product apart. • ePRO advantages: Streamline trials with effective electronic data collection. • Regulatory compliance: Align your trials with FDA and EMA expectations through patient-centric strategies. Gain valuable insights on integrating PROs effectively: https://lnkd.in/gJ4es6X5
Building Teams that Shape the Future | Culture Influencer | Ultimate People Connector | Nerd at Heart |
Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Take a look at our recent blog that explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/e8azDXJ4 #clinicaltrials #research #drugdevelopment Fortrea
Unlocking the full picture in cancer treatment goes beyond survival – it's about enhancing Quality of Life (QoL). Read Kelly Dumais's article on how prioritizing patient-reported outcomes (PROs) can enhance study designs and elevate your drug's market position: • PROs in study design: Uncover how patient insights enhance oncology trials. • Therapy differentiation: Learn the role of PROs in setting your product apart. • ePRO advantages: Streamline trials with effective electronic data collection. • Regulatory compliance: Align your trials with FDA and EMA expectations through patient-centric strategies. Gain valuable insights on integrating PROs effectively: https://lnkd.in/eVGRq_sh
Business Development Director at Fortrea (formerly Covance, Labcorp). Supporting clinical development Phase I-IV for biotech companies
Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Fortrea's blog explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/gsMyyaPP #clinicaltrials #research #drugdevelopment
Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Fortrea's blog explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/eZXGrY9E #clinicaltrials #research #drugdevelopment
Nano Medicine l Nano Drug Delivery l Bio-Nanotech l Precision Medicine l Personalised Medicine I Machine Learning l
9moVery pertinent insights Ashley et al